Clinical trial
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
NCT00451763 · University of Sao Paulo, Other · Completed
Key facts
| NCT number | NCT00451763 |
|---|---|
| Title | Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia |
| Official title | Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia |
| Lead sponsor | University of Sao Paulo, Other |
| Collaborators | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Retina, Telangiectasis |
| Intervention type | Drug |
| Interventions | Intravitreal Injection of Bevacizumab (1.25 mg/0.05ml) |
| Enrollment | 31 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Mar 23, 2007 |
| Last update posted | Jul 23, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: